Review for "Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add‐on to metformin with or without sulfonylurea in patients with type 2 diabetes: A randomized, parallel‐design, open‐label, phase 3 trial"